Suzhou R&D Center
Nantong — Single-Use Bioprocessing
Lanzhou — Chromatography Resin
Suzhou — Bioprocessing Hardware/Filtration Products
Shanghai — Digitalisation & Automation
Beijing, Shanghai, Guangzhou,
Chengdu, Jinan, Suzhou, Wuhan
The Bio-Link R&D Center is located in Suzhou City, Jiangsu Province. Covering 3,000 square meters, it consists of R&D offices, an exhibition area, an application center, a scientific instrument research lab, a machinery and equipment area, and other functional areas. The R&D center will allow Bio- Link to further create its upstream and downstream innovative bioprocessing products and solutions. While continuing to promote process innovation and expand the product portfolios, Bio-Link aims to foster an ecosystem where the company's growth is driven by its R&D innovation, manufacturing, and service capabilities.
The Single-use Bioprocessing Manufacturing Site of Bio-Link is situated in the Jiangsu Province's Nantong City, boasting a substantial area of over 27,000 square meters, and staff strength exceeding 200. The investment of 200 million CNY has facilitated the annual production capacity of two million single-use bioprocessing consumables and ten million injection mold pieces. The cleanrooms for single-use consumables are segregated into Phases I, II, and III, covering a total area of 7,360 square meters and certified with ISO9001 and ISO13485. In addition, Phase IV's hardware workshop includes a 2,150-square-meter sheet metal shop and a 1,400-square-meter mold workshop. Moreover, Phase V's hydration plant produces five million liters annually, while the validation center provides customers with extractable and leachable validation services.
Bio-Link's manufacturing facility for chromatography resins is located in Lanzhou City, Gansu Province. The site, covering an area of 7,000 square meters and benefiting from an investment of over 100 million CNY, is staffed by approximately 100 employees. It is responsible for the development and production of purification and cell culture products such as chromatography resins and mini vectors. Currently, the facility boasts a 500L chromatography resins production line, a well-equipped quality control laboratory, and holds ISO9001 certification. Working across five chromatography principles, namely gel filtration chromatography, Ion Exchange Column Chromatography, Hydrophobic Interaction Chromatography, Affinity Chromatography, and Multimodal Chromatography, the site produces dextran-based matrices, agarose-based matrices, and hydroxyapatite chromatography resins. With a projected annual production capacity of 50,000 liters, this facility is poised for continued success.